These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34192861)

  • 21. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
    Yang Y; Ma X; Wang Y; Ding X
    Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an ensemble machine-learning model for predicting early mortality among patients with bone metastases of hepatocellular carcinoma.
    Long Z; Yi M; Qin Y; Ye Q; Che X; Wang S; Lei M
    Front Oncol; 2023; 13():1144039. PubMed ID: 36890826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning methods for accurately predicting survival and guiding treatment in stage I and II hepatocellular carcinoma.
    Li X; Bao H; Shi Y; Zhu W; Peng Z; Yan L; Chen J; Shu X
    Medicine (Baltimore); 2023 Nov; 102(45):e35892. PubMed ID: 37960763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel nomograms based on microvascular invasion grade for early-stage hepatocellular carcinoma after curative hepatectomy.
    Chen H; Ye H; Ye L; Lin F; Shi Y; Zhong A; Guan G; Zhuang J
    Sci Rep; 2024 Feb; 14(1):3470. PubMed ID: 38342950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy.
    Qiu X; Gao J; Yang J; Hu J; Hu W; Kong L; Lu JJ
    Front Oncol; 2020; 10():551420. PubMed ID: 33194609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
    Liu R; Wu S; Yu HY; Zeng K; Liang Z; Li S; Hu Y; Yang Y; Ye L
    Heliyon; 2023 Nov; 9(11):e22458. PubMed ID: 38034691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
    Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis.
    Yan L; Gao N; Ai F; Zhao Y; Kang Y; Chen J; Weng Y
    Front Oncol; 2022; 12():967758. PubMed ID: 36072795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection.
    Bai S; Yang P; Wei Y; Wang J; Lu C; Xia Y; Si A; Zhang B; Shen F; Tan Y; Wang K
    Front Oncol; 2023; 13():1166327. PubMed ID: 37152055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
    Minami T; Sato M; Toyoda H; Yasuda S; Yamada T; Nakatsuka T; Enooku K; Nakagawa H; Fujinaga H; Izumiya M; Tanaka Y; Otsuka M; Ohki T; Arai M; Asaoka Y; Tanaka A; Yasuda K; Miura H; Ogata I; Kamoshida T; Inoue K; Nakagomi R; Akamatsu M; Mitsui H; Fujie H; Ogura K; Uchino K; Yoshida H; Hanajiri K; Wada T; Kurai K; Maekawa H; Kondo Y; Obi S; Teratani T; Masaki N; Nagashima K; Ishikawa T; Kato N; Yotsuyanagi H; Moriya K; Kumada T; Fujishiro M; Koike K; Tateishi R
    J Hepatol; 2023 Jun; ():. PubMed ID: 37716372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma.
    Lin K; Huang Q; Wang L; Zeng J; Ding Z; Liu H; Fu J; Guo P; Chen Z; Zeng Y; Zhou W; Liu J
    Front Oncol; 2021; 11():612588. PubMed ID: 33680963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma.
    Lin H; Zeng L; Yang J; Hu W; Zhu Y
    Front Oncol; 2021; 11():608260. PubMed ID: 33738252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
    Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
    Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study.
    Wu MY; Qiao Q; Wang K; Ji GW; Cai B; Li XC
    Cancer Manag Res; 2020; 12():3503-3512. PubMed ID: 32523380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a deep learning-based survival prediction model for pediatric glioma patients: A retrospective study using the SEER database and Chinese data.
    Jiao Y; Ye J; Zhao W; Fan Z; Kou Y; Guo S; Chao M; Fan C; Ji P; Liu J; Zhai Y; Wang Y; Wang N; Wang L
    Comput Biol Med; 2024 Nov; 182():109185. PubMed ID: 39341114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
    Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.